This model identified 18 (7.53%) and 3 (3.75%) ACPA-positive male cases to have ORs for seropositive RA>20 (lifetime risk >22%) in WTCCC and UKRAGG respectively; no controls had ORs>20. The gene discussed is PRTN3; the disease is rheumatoid arthritis.